The myeloid blood cell differentiation-inducing protein MGI-2A is interleukin-6.

No abstract is available for this paper.

• Publication year

  1988

• Venue

  Blood

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1182/blood.v72.6.2070.bloodjournal7262070PMID 3264198
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• In vivo control of differentiation of myeloid leukemic cells by recombinant granulocyte-macrophage colony-stimulating factor and interleukin 3.

  1988cited by this paper
• Multiple actions of interleukin 6 within a cytokine network.

  1988cited by this paper
• Target‐cell specificity of hematopoietic regulatory proteins for different clones of myeloid leukemic cells: Two regulators secreted by krebs carcinoma cells

  1988cited by this paper
• The human hematopoietic colony-stimulating factors.

  1987cited by this paper
• The Wellcome Foundation Lecture, 1986 - The molecular regulators of normal and leukaemic blood cells

  1987cited by this paper
• Human beta 2 interferon and B-cell differentiation factor BSF-2 are identical.

  1987cited by this paper
• Regulation of cell‐surface receptors for hematopoietic differentiation‐inducing protein MGI‐2 on normal and leukemic myeloid cells

  1987cited by this paper
• The molecular control of blood cell development.

  1987cited by this paper
• Structure and expression of cDNA and genes for human interferon‐beta‐2, a distinct species inducible by growth‐stimulatory cytokines.

  1986cited by this paper
• Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin

  1986cited by this paper
• Granulocyte-macrophage colony-stimulating factors

  1985cited by this paper
• Purification of a factor inducing differentiation of mouse myeloid leukemic M1 cells from conditioned medium of mouse fibroblast L929 cells.

  1984cited by this paper
• Regulation and role of different macrophage‐ and granulocyte‐inducing proteins in normal and leukemic myeloid cells

  1982cited by this paper
• Characterization of macrophage- and granulocyte-inducing proteins for normal and leukemic myeloid cells produced by the Krebs ascites tumor.

  1981cited by this paper
• Separation of different molecular forms of macrophage‐ and granulocyte‐inducing proteins for normal and leukemic myeloid cells

  1980cited by this paper
• Genetic dissection of the control of normal differentiation in myeloid leukemic cells.

  1977cited by this paper
• Control of lysozyme induction in the differentiation of myeloid leukemic cells.

  1976cited by this paper
• Control of normal differentiation of myeloid leukemic cells to macrophages and granulocytes.

  1973cited by this paper
• Differentiation of a cell line of myeloid leukemia

  1969cited by this paper

• IL-6 Blockade in Cytokine Storm Syndromes.

  2024cites this paper
• Molecular mechanisms and clinical impact of biologic therapies in severe asthma.

  2024cites this paper
• The Two-Faced Cytokine IL-6 in Host Defense and Diseases

  2018cites this paper
• The role of the interleukin (IL)-6/IL-6 receptor axis in cancer.

  2018cites this paper
• The Leo Sachs' legacy: a pioneer's journey through hematopoiesis.

  2017cites this paper
• E2F1 transcription factor and its impact on growth factor and cytokine signaling.

  2016cites this paper
• Ageing, exercise and the chemistry of inflammation

  2015cites this paper
• Phosphatidylinositol 3-Kinase and Insulin Receptor Substrate-1 Gene Polymorphism / Adipocytokines Interaction in Pathogenesis of Insulin Resistance among Egyptian Patients : A Pilot Study

  2015cites this paper
• Interleukin-6: Biology, signaling and strategies of blockade.

  2015cites this paper
• Toxicity to the hematopoietic and lymphoid organs of piglets treated with a therapeutic dose of florfenicol.

  2014influential citation
• Cytokine networking of innate immunity cells: a potential target of therapy.

  2014cites this paper
• Pioneer of hematopoietic colony-stimulating factors: Leo Sachs (1924–2013)

  2014cites this paper
• enforced expression of the SCL transcription factor leukemia inhibitory factor/oncostatin-M/interleukin-6: the effect of Differential regulation of macrophage differentiation in response to

  2013cites this paper
• marrow and peripheral blood cells of humans and rhesus monkeys Flow cytometric detection of receptors for interleukin-6 on bone

  2011cites this paper
• Impact of Staphylococcus aureus biofilm conditioned medium on inflammation and epithelialization in human keratinocytes

  2011cites this paper
• The role of Interleukin-6 in nervous regeneration and functional recovery in organotypic hippocampal slice cultures

  2010cites this paper
• cell progenitor in an acute myeloid leukemia Identification of a malignant counterpart of the monocyte-dendritic

  2010cites this paper
• Prime-Boost Vaccination Using Chemokine-Fused gp120 DNA and HIV Envelope Peptides Activates Both Immediate and Long-Term Memory Cellular Responses in Rhesus Macaques

  2010cites this paper
• Interleukin-6: from identification of the cytokine to development of targeted treatments.

  2010cites this paper
• Proinflammatory cytokines in breast cancer: mechanisms of action and potential targets for therapeutics.

  2010cites this paper
• Untersuchungen zum Einfluss der Zytokine CD40L, IL-6 und IL-10 auf die terminale Differenzierung der B-Lymphozyten des Haushuhns

  2009cites this paper
• Interleukin 6 – biological activities and role in rheumatoid arthritis pathogenesis

  2009cites this paper
• The immunomodulatory role of angiocidin, a novel angiogenesis inhibitor.

  2009cites this paper
• The Critical Role of the Colony-Stimulating Factor-1 Receptor in the Differentiation of Myeloblastic Leukemia Cells

  2008cites this paper
• Roles of IL-6-gp130 Signaling in Vascular Inflammation

  2008cites this paper
• Interleukin-6: discovery of a pleiotropic cytokine

  2006cites this paper
• Clinical studies in patients with Castleman’s disease, Crohn’s disease, and rheumatoid arthritis in Japan

  2005cites this paper
• Human recombinant interleukin-6 enhances antibody-dependent cellular cytotoxicity of human tumor cells mediated by human peripheral blood mononuclear cells

  2005cites this paper
• Interleukin-6: from basic science to medicine--40 years in immunology.

  2005cites this paper
• IL-6 protects pancreatic islet beta cells from pro-inflammatory cytokines-induced cell death and functional impairment in vitro and in vivo.

  2004cites this paper
• Modulation of T cell development and activation by novel members of the Schlafen (slfn) gene family harbouring an RNA helicase-like motif.

  2004cites this paper
• IL-6 cytokine family and signal transduction: a model of the cytokine system

  2004cites this paper
• Importance of the vagus nerve for fever and neutrophil migration induced by intraperitoneal LPS injection

  2003cites this paper
• Over-Expression of csrc or v-src in Bone Marrow Stromal Cells Stimulates Hematopoiesis in Long-Term Bone Marrow Culture

  2003cites this paper
• The paradigm of IL-6: from basic science to medicine

  2002cites this paper
• Cytokine control of developmental programs in normal hematopoiesis and leukemia

  2002cites this paper
• Epigenetics wins over genetics: induction of differentiation in tumor cells.

  2002cites this paper
• Colony-stimulating factor-1 (CSF-1) receptor-mediated macrophage differentiation in myeloid cells: a role for tyrosine 559-dependent protein phosphatase 2A (PP2A) activity.

  2001cites this paper
• PDFlib PLOP: PDF Linearization, Optimization, Protection Page inserted by evaluation version

  2001cites this paper
• Interleukin-6 inhibits radiation induced apoptosis in pancreatic cancer cells.

  2001cites this paper
• CD80 (B7-1) expression on human acute myeloid leukaemic cells cultured with GM-CSF, IL-3 and IL-6

  2001cites this paper
• Interleukin‐6 (IL6) and cellular response to facial nerve injury: effects on lymphocyte recruitment, early microglial activation and axonal outgrowth in IL6‐deficient mice

  2001cites this paper
• Inhibitory effects of anti-inflammatory drugs on interleukin-6 bioactivity.

  2001cites this paper
• Lineage Commitment and Maturation Induction in Normal and Leukemic Preprogenitor Cells

  2001cites this paper
• The Role of Leukemia Inhibitory Factor in Cancer and Cancer Metastasis

  2001cites this paper
• STAT5 Induces Macrophage Differentiation of M1 Leukemia Cells Through Activation of IL-6 Production Mediated by NF-κB p651

  2001cites this paper
• Differentiation commitment and regulator-specific granulocyte–macrophage maturation in a novel pro-B murine leukemic cell line

  2000cites this paper
• Interleukin-6 and other gp130-dependent cytokines selectively inhibit proliferation of macrophage-lineage hemopoietic progenitor cells.

  2000cites this paper
• Oncostatin M‐Mediated Growth Inhibition of Human Glioblastoma Cells Does Not Depend on Stat3 or on Mitogen‐Activated Protein Kinase Activation

  2000cites this paper
• Protein-tyrosine phosphatase PTPepsilon C inhibits Jak-STAT signaling and differentiation induced by interleukin-6 and leukemia inhibitory factor in M1 leukemia cells.

  2000cites this paper
• Differentiation of M1 Myeloid Precursor Cells into Macrophages Results in Binding and Infection by Theiler’s Murine Encephalomyelitis Virus and Apoptosis

  1999cites this paper
• Expression of BCR – ABL in M1 myeloid leukemia cells induces differentiation without arresting proliferation

  1999cites this paper
• Enhanced expression of interleukin-6 in chronic hepatitis C.

  1999cites this paper
• Novel neurotrophin-1/B cell-stimulating factor-3: a cytokine of the IL-6 family.

  1999cites this paper
• Leukemia inhibitory factor: part of a large ingathering family.

  1998cites this paper
• Cytokine and interferon research in Israel.

  1998cites this paper
• Identification of a novel apoptosis-inducing factor derived from leukemic cells: endothelial interleukin-8, but not monocyte-derived, induces apoptosis in leukemic cells.

  1998cites this paper
• Synergistic effects of colony-stimulating factor 1 and leukemia inhibitory factor in inducing early myeloid cell differentiation.

  1998cites this paper
• CD34 expression by embryonic hematopoietic and endothelial cells does not require c-Myb.

  1998cites this paper
• Different mechanisms for suppression of apoptosis by cytokines and calcium mobilizing compounds.

  1998cites this paper
• The Gfi-1B Proto-Oncoprotein Repressesp21WAF1 and Inhibits Myeloid Cell Differentiation

  1998cites this paper
• Interleukin 6 and its receptor: ten years later.

  1998cites this paper
• Expression of the Wilms' tumor suppressor gene, WT1, is upregulated by leukemia inhibitory factor and induces monocytic differentiation in M1 leukemic cells.

  1998cites this paper
• Association of Stat3-dependent transcriptional activation of p19INK4D with IL-6-induced growth arrest.

  1997cites this paper
• Signaling mechanisms through gp130: a model of the cytokine system.

  1997cites this paper
• Rapamycin antagonizes interleukin-6 mediated growth arrest and differentiation of myeloblastic M1 cells.

  1997cites this paper
• A phase I study of interleukin-6 after autologous bone marrow transplantation for patients with poor prognosis Hodgkin's disease.

  1997cites this paper
• Gene expression, biological effects and clinical aspects of lymphokines.

  1997cites this paper
• The Wilms tumor suppressor gene WT1 induces G1 arrest and apoptosis in myeloblastic leukemia M1 cells

  1997cites this paper
• Impaired neuroglial activation in interleukin‐6 deficient mice

  1997cites this paper
• Regulation of CD34 expression in differentiating M1 cells.

  1997cites this paper
• Complex effects of interleukin 6 on clonogenic blast cell growth in acute myeloblastic leukemia.

  1997cites this paper
• The human IL-11 receptor requires gp130 for signalling: demonstration by molecular cloning of the receptor.

  1996cites this paper
• Molecular and cellular biology of interleukin-6 and its receptor.

  1996cites this paper
• Regulation of granulocyte-macrophage colony-stimulating factor (GM-CSF) receptors in a GM-CSF-dependent human myeloid leukemia cell line (AML-193) by interleukin-6.

  1996cites this paper
• Interleukin-6-Type Cytokines In Vivo: Regulated Bioavailability 1

  1996cites this paper
• Interleukin 6 in diseases: cause or cure?

  1996cites this paper
• Regulation of Interleukin-6 Expression in Porcine Immune Cells

  1996cites this paper
• A soluble interleukin 6 receptor isolated from conditioned medium of human breast cancer cells is encoded by a differentially spliced mRNA.

  1996cites this paper
• Interactions between leukemia cells and bone marrow stromal cells: stroma-supported growth vs. serum dependence and the roles of TGF-beta and M-CSF.

  1996cites this paper
• Cytokine regulated differentiation and apoptosis of Myb-transformed cell lines

  1996cites this paper
• Murine flt3 ligand protects M1 leukemic cells from LIF-induced differentiation and suppression of self-renewal.

  1996cites this paper
• The control of hematopoiesis and leukemia: from basic biology to the clinic.

  1996cites this paper
• Differentiation and growth arrest signals are generated through the cytoplasmic region of gp130 that is essential for Stat3 activation.

  1996cites this paper
• Interleukin 6 acts as a paracrine growth factor in human mammary carcinoma cell lines.

  1996cites this paper
• Immunotherapy of malignant melanoma.

  1996cites this paper
• Signaling molecules and neuroglial activation in the injured central nervous system.

  1996cites this paper
• Cytokine production by a megakaryocytic cell line

  1996cites this paper
• A central role for Stat3 in IL‐6‐induced regulation of growth and differentiation in M1 leukemia cells.

  1996cites this paper
• The effect of interleukin‐6 and soluble interleukin‐6 receptor protein on the bone resorptive activity of human osteoclasts generated in vitro

  1995cites this paper
• Interleukin‐6 Production by Schwann Cells and Induction in Sciatic Nerve Injury

  1995cites this paper
• Differential regulation of macrophage differentiation in response to leukemia inhibitory factor/oncostatin-M/interleukin-6: the effect of enforced expression of the SCL transcription factor.

  1995cites this paper
• Interleukin‐6‐Type Cytokines in Myeloproliferative Disease a

  1995cites this paper
• Full-length but not truncated CD34 inhibits hematopoietic cell differentiation of M1 cells.

  1995cites this paper
• Expression and phosphorylation of BiP/GRP78, a molecular chaperone in the endoplasmic reticulum, during the differentiation of a mouse myeloblastic cell line.

  1995cites this paper
• Interleukin-6 family of cytokines and gp130.

  1995cites this paper
• Hemopoietic regulators and leukemia development: a personal retrospective.

  1994cites this paper
• Activation of JAK2 kinase mediated by the interleukin 6 signal transducer gp130.

  1994cites this paper
• The Network of Hematopoietic Cytokines

  1994cites this paper
• Interleukin-6 is required in vivo for the regulation of stem cells and committed progenitors of the hematopoietic system.

  1994cites this paper